AI-generated summary
The authors compared 25 patients who received Longidaza combined with magnetic-laser therapy after percutaneous kidney stone surgery with 24 control patients who received standard care. At six months, one patient (4%) in the treated group had pyeloectasis and UPJ obstruction, versus four patients (16.7%) in the control group. The authors recommend this comprehensive postoperative prevention approach.
- Participants
- 49
- Who or what was studied
- Patients with urolithiasis who underwent percutaneous puncture nephrolitholapaxy (25 in the study group, 24 in the control group)
- Limits stated in the abstract
- The abstract describes a small two-group study with a short six-month follow-up, and does not report randomization or statistical testing.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Control group, Inflammation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.